Inventor · disambiguated record
Esmira Naftali
Also filed as: NAFTALI ESMIRA
1 granted patent·6 pending applications·6 citations·filing 2004–2021
30Inventor score
Top patents by PatentIndex Score
7 records- 0167US7294687B2Parenteral formulations of a peptide for the treatment of systemic lupus erythematosusTEVA PHARMA·Filed 2004·Granted Nov 13, 2007·6 cites·25 claims
- 0260US2008287366A1Parenteral formulations of a peptide for the treatment of systemic lupus erythematosusTEVA PHARMA·Filed 2007·Application pending·0 cites
- 0356US2009169559A1Parenteral formulations of peptides for the treatment of systemic lupus erythematosusTEVA PHARMA·Filed 2008·Application pending·0 cites
- 0446US2013023485A1Parenteral formulations of peptides for the treatment of systematic lupus erythematosusTEVA PHARMA·Filed 2012·Application pending·0 cites
- 0545US2005008634A1Parenteral formulations of peptides for the treatment of systemic lupus erythematosusFiled 2004·Application pending·0 cites
- 0636US2023190863A1Pharmaceutical compositions and anti-viral uses thereofCODE PHARMA B V·Filed 2021·Application pending·0 cites
- 0734US2022233652A1Pharmaceutical Compositions Comprising Integration-Promoting PeptidesZION MEDICAL B V·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Esmira Naftali files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →